Janus Henderson Group plc Reports 13.6% Ownership in Vistagen Therapeutics, Inc.

Janus Henderson Group plc has filed a Schedule 13G with the SEC, reporting a 13.6% ownership stake in Vistagen Therapeutics, Inc. The filing indicates that Janus Henderson Group plc, through its indirect subsidiaries JHIUS, JHIUKL, and JHIAIFML, beneficially owns 4,165,767 shares of Vistagen's common stock. The shares are held in the ordinary course of business and not for the purpose of influencing control of the issuer. The filing also includes a power of attorney granted to Kristin Mariani and Caroline Barotti for executing documents related to ownership or control-person reporting requirements.